Pfm Health Sciences, LP Arcus Biosciences, Inc. Transaction History

Pfm Health Sciences, LP

$1.71 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$16.97 - $22.03 $2.63 Million - $3.41 Million	-154,891 Reduced 9.93%	1,405,056 $28.5 Million
Q1 2023 May 15, 2023	SELL	$15.96 - $23.15 $18.2 Million - $26.5 Million	-1,143,340 Reduced 42.29%	1,559,947 $28.5 Million
Q4 2022 Feb 14, 2023	SELL	$19.7 - $35.71 $13.4 Million - $24.3 Million	-679,946 Reduced 20.1%	2,703,287 $55.9 Million
Q3 2022 Nov 14, 2022	BUY	$23.23 - $30.07 $854,283 - $1.11 Million	36,775 Added 1.1%	3,383,233 $88.5 Million
Q2 2022 Aug 15, 2022	SELL	$17.23 - $37.73 $1.46 Million - $3.19 Million	-84,552 Reduced 2.46%	3,346,458 $84.8 Million
Q3 2021 Nov 15, 2021	SELL	$26.93 - $37.68 $1.81 Million - $2.53 Million	-67,250 Reduced 1.92%	3,431,010 $120 Million
Q1 2021 May 17, 2021	BUY	$26.16 - $41.39 $3.26 Million - $5.17 Million	124,800 Added 3.7%	3,498,260 $98.2 Million
Q4 2020 Feb 16, 2021	BUY	$17.0 - $32.36 $14.2 Million - $27.1 Million	836,528 Added 32.97%	3,373,460 $87.6 Million
Q3 2020 Nov 16, 2020	BUY	$17.14 - $25.47 $13.7 Million - $20.4 Million	801,351 Added 46.17%	2,536,932 $43.5 Million
Q2 2020 Aug 14, 2020	BUY	$13.97 - $36.56 $12.9 Million - $33.9 Million	926,070 Added 114.4%	1,735,581 $42.9 Million
Q1 2020 May 15, 2020	BUY	$8.78 - $19.28 $7.11 Million - $15.6 Million	809,511 New	809,511 $11.2 Million
Q1 2019 May 15, 2019	SELL	$8.95 - $12.49 $1.98 Million - $2.76 Million	-220,976 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$9.74 - $14.5 $4.9 Million - $7.29 Million	-502,858 Reduced 69.47%	220,976 $2.38 Million
Q3 2018 Nov 13, 2018	SELL	$10.88 - $14.95 $483,561 - $664,452	-44,445 Reduced 5.79%	723,834 $10.1 Million
Q2 2018 Aug 14, 2018	SELL	$12.24 - $17.05 $2.02 Million - $2.81 Million	-165,007 Reduced 17.68%	768,279 $9.4 Million
Q1 2018 May 15, 2018	BUY	$15.44 - $17.71 $14.4 Million - $16.5 Million	933,286 New	933,286 $14.4 Million

Others Institutions Holding RCUS

# of Institutions

201

Shares Held

51.7M

Call Options Held

236K

Put Options Held

141K

Black Rock Inc. New York, NY

9.76M
Shares

$154 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.47M
Shares

$86.4 Million
0.0% of portfolio
Woodline Partners LP San Francisco, CA

3.48M
Shares

$55 Million
0.48% of portfolio
State Street Corp Boston, MA

3.01M
Shares

$47.6 Million
0.0% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

2.44M
Shares

$38.5 Million
0.1% of portfolio

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.14B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.

Account